SALIX PHARMACEUTICALS LTD Future Amortization Expense, Year Four (Deprecated 2012-01-31)
SALIX PHARMACEUTICALS LTD reported Future Amortization Expense, Year Four (Deprecated 2012-01-31) of $45.40 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearFour · last filed 2012-02-28
- SALIX PHARMACEUTICALS LTD future amortization expense, year four (deprecated 2012-01-31) for fiscal 2011 was $45.40M.
| Period end | Future Amortization Expense, Year Four (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | $45.40M 10-K · filed 2012-02-28 |